Department of Ophthalmology

Risk factors for failing sub-Tenon’s triamcinolone acetonide for uveitic macular edema

Written by Journal of Ophthalmic Inflammation and Infection | February 02, 2024

Researchers from the CU Department of Ophthalmology write that sub-Tenon’s triamcinolone acetonide is an effective therapy for treating uveitic macular edema, particularly for patients with lower baseline central subfield thickness.